View

The Study

Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of Aspirin.

In simple terms

This study is like a fair test where people were randomly given either aspirin or a sugar pill, and then researchers watched what happened over many years. They found that people with a certain blood condition (CHIP) had more bleeding, but aspirin didn't seem to help or hurt them more than others. But because they looked at small groups, we can't be super sure about those smaller findings.

80%

Analysis score

80/ 90

Maximum 90 for a randomized controlled trial.

Where the score came from

Reporting0
Methodology100
Publication100
Statistical100
Study type (basis of the score)
Randomized Controlled Trial
Level 1b - Individual RCT
What’s the bottom line?

Some older people have a harmless blood mutation called CHIP. This study tested if taking low-dose aspirin helps them avoid heart attacks or strokes.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Randomized Trials
Level 1b
80

80 / 100

Quality score

Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.

Can establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

  1. 1The bleeding risk increase is small but meaningful for older adults already at risk for bleeding; aspirin offers no extra benefit for CHIP carriers.
  2. 223% of participants had CHIP.
  3. 3CHIP didn't raise heart attack or stroke risk.
  4. 4But people with CHIP had 24% more serious bleeding.
  5. 5Aspirin didn't help or hurt CHIP carriers more than others.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data

Publication

Journal

JAMA cardiology

Year

2025

Authors

Zoe K. McQuilten, L. T. Thao, Alexander G. Bick, Sean Byars, Andrew T. Chan, Leslie Ford, Anna Leichter, John J McNeil, A. Murray, A. Murphy, S. Orchard, James Phung, Hayley S. Ramshaw, Jasmine Singh, Andrew M Tonkin, Asad Umar, R. Wolfe, E. Wood, Robyn L. Woods, P. Lacaze, David J. Curtis

Open Access
3 citations
Analysis v5
Fit Body Science verdict — we translate health studies into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.